explore -WSS

explore

author：focus 2025-09-06 02:10:35 - browse：215

foreign-trained health professionals — Adobe

The pharmaceutical industry has been up in arms over Medicare’s first list of 10 prescription drugs that will be subject to negotiations. But other major parts of the health care industry — hospitals, doctors, and other providers — have refrained from either lending support or criticizing the government’s process.

The American Hospital Association, the industry’s main lobbying group, told STAT it is “not commenting on this issue right now.” The American Medical Association had no comment and deferred to other physician trade groups. The Federation of American Hospitals offered no statement.

The American Health Care Association, which lobbies on behalf of nursing homes, did not comment on the list of 10 drugs or Medicare’s negotiating power. But it said in a statement that “many nursing home residents have multiple chronic conditions that require several medications, so any efforts at reducing their out-of-pocket costs would be welcome.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： Australia’s approach to dialysis celebrates life

leisure time

explore

WSS

First recipient of genetically engineered pig kidney has died

Readout LOUD podcast: brain research, obesity drug sales, Novartis

Psilocybin's anti

Apellis safety probe of eye disease drug centers on injection needle

First recipient of genetically engineered pig kidney has died

Feds fine Medicare Advantage plans for overcharging members

Wikipedia

explore

focus

How one medical school became remarkably diverse

In science, is the line between industry and academia shifting?

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Study: People of West African ancestry at greater risk of cardiac amyloidosis

Guidelines to prevent youth baseball injuries need more muscle

Neuroscience startup Neumora files for IPO

Drug repurposing or repositioning? The language matters

After gene therapy, two congenitally deaf children hear for the first time

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Medicare explains how it will choose drugs for negotiation

explore

Apple Watch's A

What do new weight loss drugs mean for bariatric surgery?

Medicare says breakthrough device reimbursement rule to come by summer

Drug firms test therapies to halt Alzheimer’s before symptoms arise

Sanofi strikes deal with Novavax, boosting the vaccine maker

Study finds new variant for Parkinson’s in African populations

knowledge

leisure time

explore

leisure time